- Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV . . .
Individuals must be tested for HIV-1 infection prior to initiating Yeztugo, and with each subsequent injection of Yeztugo, using a test approved or cleared by the FDA for the diagnosis of acute or primary HIV-1 infection
- Yeztugo: Uses, Dosage, Side Effects, Warnings - Drugs. com
Yeztugo is used for HIV-1 PrEP to reduce the risk of getting HIV-1 in adults and adolescents who weigh at least 77 pounds (at least 35 kg) The initial dose consists of 2 Yeztugo injections (day 1) and 2 Yeztugo tablets (day 1 and day 2)
- label - accessdata. fda. gov
YEZTUGO, a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor, is indicated for prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at
- For HCPs | Yeztugo® (lenacapavir) Dosing and Administration
This document is in response to your request for information regarding Yeztugo® (lenacapavir [LEN]) and oral and subcutaneous dosing and administration Some data may be outside of the US FDA-approved prescribing information
- Yeztugo: Dosage, side effects, uses, interactions, cost, and more
Yeztugo (lenacapavir) is a prescription drug used as PrEP (pre-exposure prophylaxis) to help prevent HIV Learn about dosage, side effects, and more
- Yeztugo (lenacapavir): Uses, Side Effects, Interactions . . . - WebMD
Find patient medical information for Yeztugo (lenacapavir) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- FDA approves powerful HIV prevention drug: What to know about Yeztugo
Called Yeztugo, the highly effective drug has inspired feverish anticipation among advocates for HIV prevention The hope is the medication could accelerate the stubbornly slow decline of HIV
- Yeztugo: Revolutionizing HIV Prevention with Twice-Yearly Injections
Approved by the U S Food and Drug Administration (FDA), this breakthrough drug offers a new option for adults and adolescents weighing at least 77 pounds, seeking to protect themselves from HIV without daily pills or frequent injections
|